Myeloperoxidase and protein oxidation in cystic fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 3 23-3, 2000, Pages

  Van Der Vliet, Albert ^a   Nguyen, Mai N ^a   Shigenaga, Mark K ^b   Eiserich, Jason P ^c   Marelich, Gregory P ^a   Cross, Carroll E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

3,3' dityrosine; 3 chlorotyrosine; 3 nitrotyrosine; Hypochlorous acid; Inflammation; Nitric oxide

Indexed keywords

3 NITROTYROSINE; HYPOCHLOROUS ACID; MYELOPEROXIDASE; NITRIC OXIDE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; INFLAMMATION; OXIDATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPUTUM ANALYSIS;

EID: 0033830339     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.3.l537     Document Type: Article

References (63)

1. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
2. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
3. Inflammatory cytokines in cystic fibrosis lungs
4. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection
5. 1 proteinase inhibitor: Implications for the pathogenesis of cystic fibrosis lung disease
6. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress
7. Oxidant-induced epithelial cell injury in idiopathic pulmonary fibrosis
8. Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro
9. Elevated plasma levels of F2a isoprostane levels in cystic fibrosis
10. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis
11. Association of myeloperoxidase with heparin: Oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme
12. Free radical production from the aerobic oxidation of reduced pyridine nucleotides catalyzed by phenazine derivatives
13. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
14. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
15. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
16. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis
17. Abnormal glutathione transport in cystic fibrosis airway epithelia
18. The biology of nitrogen oxides in the airways
19. Nitric oxide metabolites in cystic fibrosis lung disease
20. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
21. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
22. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
23. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species
24. 2 radicals
25. 2 integrin (Mac-1, CD11b/CD18)
26. An activity in rat tissues that modifies nitrotyrosine-containing proteins
27. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells
28. Antimicrobial activity of myeloperoxidase
29. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis
30. Myeloperoxidase genetic polymorphism and lung cancer risk
31. Exhaled nitric oxide in paediatric asthma and cystic fibrosis
32. Cystic fibrosis in adults. From researcher to practitioner
33. Lack of inducible nitric oxide synthase in bronchial epithelium: A possible mechanism of susceptibility to infection in cystic fibrosis
34. 1-proteinase inhibitor by tetranitromethane. Structure-function relationship
35. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum
36. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
37. Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection
38. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide
39. Spontaneous and induced sputum to measure indices of airway inflammation in asthma
40. Effects of cystic fibrosis airway secretions on rat lung: Role of neutrophil elastase
41. Sputum peroxidase activity cotrelates with the severity of lung disease in cystic fibrosis
42. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia
43. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
44. Culture of conducting airway epithelial cells in serum-free medium
45. Cystic fibrosis
46. Systemic deficiency of glutathione in cystic fibrosis
47. Isolation and characterization of a peroxidase from the airway
48. Inflammation and NO(x)-induced nitration: Assay for 3-nitrotyrosine by HPLC with electrochemical detection
49. Amination of tyrosine in liver cytosol protein of male F344 rats treated with 2-nitropropane, 2-nitrobutane, 3-nitropentane, or acetoxime
50. Coordination expression of a 45 kD protein and ozone toxicity in a human bronchial epithelial cell line
51. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis
52. Deleterious effects of purulent sputum sol on human ciliary function in vitro: At least two factors identified
53. Leukocyte myeloperoxidase and salivary lactoperoxidase: Identification and quantitation in human mixed saliva
54. Covalent cross-linking of immune complexes by oxygen radicals and nitrite
55. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity
56. Oxidative stress in cystic fibrosis: Does it occur and does it matter?
57. Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease?
58. Analysis of aromatic nitration, chlorination and hydroxylation by gas chromatography-mass spectrometry
59. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro
60. Oxygen free radicals and antioxidants in cystic fibrosis: The concept of an oxidant-antioxidant imbalance
61. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum
62. Inflammation and CFTR: Might neutrophils be the key in cystic fibrosis?
63. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis